{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:20:15Z","timestamp":1780478415703,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA262788"],"award-info":[{"award-number":["R01CA262788"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21CA264627"],"award-info":[{"award-number":["R21CA264627"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ogun Ministry of Education Science and Technology","doi-asserted-by":"publisher","award":["2020R1A2C2015026"],"award-info":[{"award-number":["2020R1A2C2015026"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ogun Ministry of Education Science and Technology","doi-asserted-by":"publisher","award":["2016M3A9B5941836"],"award-info":[{"award-number":["2016M3A9B5941836"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021079","name":"Lizanell and Colbert Coldwell Foundation","doi-asserted-by":"publisher","award":["NAID20220187"],"award-info":[{"award-number":["NAID20220187"]}],"id":[{"id":"10.13039\/100021079","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jconrel.2025.114273","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:38:10Z","timestamp":1758940690000},"page":"114273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Horizontal blocking of metastatic growth factors signaling by low molecular weight heparin derivative to control ovarian cancer progression"],"prefix":"10.1016","volume":"387","author":[{"given":"Farzana","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R.","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Uk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriya","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Heon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taslim A.","family":"Al-Hilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngro","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2024","key":"10.1016\/j.jconrel.2025.114273_bb0005","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.114273_bb0010","series-title":"Overcoming Drug Resistance in Gynecologic Cancers","first-page":"283","article-title":"Chapter 12 - ovarian cancer: Targeted therapies and mechanisms of resistance","author":"Sarvepalli","year":"2021"},{"key":"10.1016\/j.jconrel.2025.114273_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071930","article-title":"Recent Progress in gene therapy for ovarian Cancer","volume":"19","author":"Ayen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114273_bb0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114273_bb0025","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","article-title":"TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment","volume":"73","author":"Yeung","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114273_bb0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12935-014-0072-1","article-title":"TGF-beta isoforms induce EMT independent migration of ovarian cancer cells","volume":"14","author":"Gao","year":"2014","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2025.114273_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025559","article-title":"Genetic variants in TGF-beta pathway are associated with ovarian cancer risk","volume":"6","author":"Yin","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jconrel.2025.114273_bb0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","article-title":"A collagen-remodeling gene signature regulated by TGF-beta signaling is associated with metastasis and poor survival in serous ovarian cancer","volume":"20","author":"Cheon","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114273_bb0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ejca.2012.06.026","article-title":"Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer","volume":"49","author":"Marchini","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114273_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2014.10.004","article-title":"The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions","volume":"46","author":"Davidson","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jconrel.2025.114273_bb0055","first-page":"277","article-title":"Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells","volume":"31","author":"Kajiyama","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2025.114273_bb0060","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.humpath.2013.05.001","article-title":"Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma","volume":"44","author":"Chen","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jconrel.2025.114273_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fonc.2012.00033","article-title":"Epithelial-mesenchymal transition in ovarian carcinoma","volume":"2","author":"Davidson","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2025.114273_bb0070","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0002-9440(10)65669-6","article-title":"Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization","volume":"153","author":"Mesiano","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2025.114273_bb0075","first-page":"5721","article-title":"Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model","volume":"9","author":"Byrne","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114273_bb0080","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/ijc.24239","article-title":"Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor","volume":"124","author":"Lee","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114273_bb0085","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1016\/j.biomaterials.2014.04.050","article-title":"Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid","volume":"35","author":"Alam","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114273_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2016.01.058","article-title":"Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate)","volume":"86","author":"Alam","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114273_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2013.12.001","article-title":"Oligomeric bile acid-mediated oral delivery of low molecular weight heparin","volume":"175","author":"Al-Hilal","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114273_bb0100","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1038\/srep04163","article-title":"Functional transformations of bile acid transporters induced by high-affinity macromolecules","volume":"4","author":"Al-Hilal","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114273_bb0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2014.11.009","article-title":"Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy","volume":"197","author":"Alam","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114273_bb0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/cr.2008.316","article-title":"Roles of TGFbeta in metastasis","volume":"19","author":"Padua","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2025.114273_bb0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canlet.2011.08.033","article-title":"Human ovarian cancer cell morphology, motility, and proliferation are differentially influenced by autocrine TGFbeta superfamily signalling","volume":"313","author":"Theriault","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.114273_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1530\/ERC-15-0383","article-title":"TGFbeta signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids","volume":"23","author":"Rafehi","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jconrel.2025.114273_bb0125","article-title":"Identification of potential key genes of TGF-beta signaling associated with the immune response and prognosis of ovarian cancer based on bioinformatics analysis","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2025.114273_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-00436-9","article-title":"Targeting TGFbeta signal transduction for cancer therapy","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114273_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B","article-title":"Heparin-protein interactions","volume":"41","author":"Capila","year":"2002","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2025.114273_bb0140","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/01.ATV.0000137189.22999.3f","article-title":"Heparin-binding domains in vascular biology","volume":"24","author":"Munoz","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2025.114273_bb0145","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1007\/s11095-008-9643-y","article-title":"Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth","volume":"25","author":"Park","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.114273_bb0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jat.2995","article-title":"Preliminary safety evaluation of a taurocholate-conjugated low-molecular-weight heparin derivative (LHT7): a potent angiogenesis inhibitor","volume":"35","author":"Alam","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.jconrel.2025.114273_bb0155","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/03639045.2015.1122609","article-title":"Safety studies on intravenous infusion of a potent angiogenesis inhibitor: taurocholate-conjugated low molecular weight heparin derivative LHT7 in preclinical models","volume":"42","author":"Alam","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2025.114273_bb0160","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI83427","article-title":"Targeting prion-like protein doppel selectively suppresses tumor angiogenesis","volume":"126","author":"Al-Hilal","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114273_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121423","article-title":"Targeting angiogenic growth factors using therapeutic glycosaminoglycans on doppel-expressing endothelial cells for blocking angiogenic signaling in cancer","volume":"283","author":"Choi","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114273_bb0170","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jconrel.2023.02.002","article-title":"Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor","volume":"355","author":"Hwang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114273_bb0175","doi-asserted-by":"crossref","first-page":"9070","DOI":"10.1016\/j.biomaterials.2012.09.002","article-title":"Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge","volume":"33","author":"Chung","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114273_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116215","article-title":"Spheroid formation and peritoneal metastasis in ovarian Cancer: the role of stromal and immune components","volume":"23","author":"Rakina","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114273_bb0185","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/cas.12987","article-title":"Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer","volume":"107","author":"Kim","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2025.114273_bb0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.jconrel.2025.114273_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jconrel.2025.114273_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071849","article-title":"Biological role of tumor\/stromal CXCR4-CXCL12-CXCR7 in MITO16A\/MaNGO-OV2 advanced ovarian Cancer patients","volume":"14","author":"D\u2019Alterio","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:55:46Z","timestamp":1780476946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925008867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":40,"alternative-id":["S0168365925008867"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114273","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Horizontal blocking of metastatic growth factors signaling by low molecular weight heparin derivative to control ovarian cancer progression","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114273"}}